MDT

89.97

+0.71%↑

VEEV

275.84

-1.9%↓

A

123.3

-0.67%↓

WBA

11.51

-0.35%↓

HQY

94.45

-2.78%↓

MDT

89.97

+0.71%↑

VEEV

275.84

-1.9%↓

A

123.3

-0.67%↓

WBA

11.51

-0.35%↓

HQY

94.45

-2.78%↓

MDT

89.97

+0.71%↑

VEEV

275.84

-1.9%↓

A

123.3

-0.67%↓

WBA

11.51

-0.35%↓

HQY

94.45

-2.78%↓

MDT

89.97

+0.71%↑

VEEV

275.84

-1.9%↓

A

123.3

-0.67%↓

WBA

11.51

-0.35%↓

HQY

94.45

-2.78%↓

MDT

89.97

+0.71%↑

VEEV

275.84

-1.9%↓

A

123.3

-0.67%↓

WBA

11.51

-0.35%↓

HQY

94.45

-2.78%↓

Search

Integra LifeSciences Holdings Corp

Fermé

SecteurSoins de santé

12.56 -4.63

Résumé

Variation du prix de l'action

24h

Actuel

Min

12.48

Max

13.16

Chiffres clés

By Trading Economics

Revenu

-45M

-25M

Ventes

-60M

383M

P/E

Moyenne du Secteur

63.02

39.564

Marge bénéficiaire

-6.61

Employés

4,396

EBITDA

-95M

-15M

Recommandations

By TipRanks

Recommandations

Neutre

Prévisions sur 12 Mois

+11.39% upside

Dividendes

By Dow Jones

Prochains Résultats

28 juil. 2025

Statistiques du Marché

By TradingEconomics

Capitalisation Boursière

-849M

1B

Ouverture précédente

17.19

Clôture précédente

12.56

Sentiment de l'Actualité

By Acuity

50%

50%

174 / 376 Classement par Healthcare

Score Technique

By Trading Central

Confiance

Strong Bearish Evidence

Integra LifeSciences Holdings Corp Graphique

Les performances passées ne sont pas un indicateur fiable des résultats futurs.

Actualités Associées

11 juil. 2025, 22:19 UTC

Acquisitions, Fusions, Rachats

FCC Approves U.S. Cellular Sale to T-Mobile

11 juil. 2025, 17:28 UTC

Principaux Mouvements du Marché

SharpLink Gaming Gains on Ethereum Purchase

11 juil. 2025, 16:57 UTC

Résultats

BASF Cuts Outlook on Global Economy Uncertainty

11 juil. 2025, 21:45 UTC

Market Talk

Fitch Affirms Germany's Rating, Sees Deficit, Debt Rising -- Market Talk

11 juil. 2025, 19:46 UTC

Acquisitions, Fusions, Rachats

Kraft Heinz Might Split Up, Report Says. What Investors Need to Know. -- Barrons.com

11 juil. 2025, 19:45 UTC

Market Talk

Crude Futures Post Back-to-Back Weekly Gains -- Market Talk

11 juil. 2025, 19:05 UTC

Market Talk

U.S. Natural Gas Futures Post Third Straight Weekly Loss -- Market Talk

11 juil. 2025, 18:18 UTC

Market Talk

Canada Officials Tight-Lipped on Next Steps in Trump Trade Talks -- Market Talk

11 juil. 2025, 17:35 UTC

Market Talk

Canada Should Target Lower Sectoral Tariffs, Import Quotas in US Trade Talks -- Market Talk

11 juil. 2025, 17:26 UTC

Market Talk

U.S. Oil Rig Count Down by 1 to 424 -- Market Talk

11 juil. 2025, 16:53 UTC

Market Talk

Crude Futures Add to Early Gains -- Market Talk

11 juil. 2025, 16:42 UTC

Résultats

BASF Cuts Outlook on Global Economic Uncertainty

11 juil. 2025, 16:08 UTC

Market Talk

Rise in Canadian Staycations May Help Explain Labor Market Strength -- Market Talk

11 juil. 2025, 16:05 UTC

Résultats

BASF Will Publish Half-Year Results on July 30

11 juil. 2025, 16:04 UTC

Market Talk

Global Equities Roundup: Market Talk

11 juil. 2025, 16:04 UTC

Market Talk

Senior Housing Shortage Gives REITs Pricing Power -- Market Talk

11 juil. 2025, 16:03 UTC

Résultats

BASF: Guidance Cut Is Due to Ongoing Macroeconomic, Geopolitical Uncertainties

11 juil. 2025, 16:02 UTC

Résultats

BASF Continues to Expect Free Cash Flow Between EUR400M and EUR800M in 2025

11 juil. 2025, 16:01 UTC

Résultats

BASF Had Seen Ebitda Before Special Items Between EUR8B and EUR8.4B in 2025

11 juil. 2025, 16:00 UTC

Résultats

BASF Now Sees Ebitda Before Special Items Between EUR7.3B and EUR7.7B in 2025

11 juil. 2025, 15:59 UTC

Résultats

BASF Cuts 2025 Earnings View

11 juil. 2025, 15:58 UTC

Résultats

Nvidia's CEO Has Sold a Million Shares. He Has Millions More to Sell. -- Barrons.com

11 juil. 2025, 15:57 UTC

Résultats

BASF 2Q EBIT Before Special Items EUR810M

11 juil. 2025, 15:54 UTC

Résultats

BASF: Analysts Had Expected 2Q Sales of EUR15.80B

11 juil. 2025, 15:54 UTC

Résultats

BASF 2Q Sales Fell 2.1% on Year

11 juil. 2025, 15:53 UTC

Résultats

BASF 2Q Sales EUR15.77B

11 juil. 2025, 15:52 UTC

Résultats

BASF: This Was in Line With Consensus Estimates

11 juil. 2025, 15:52 UTC

Résultats

BASF 2Q Ebitda Before Special Items EUR1.77B

11 juil. 2025, 15:49 UTC

Résultats

BASF Reports Preliminary 2Q Figures, Adjusts 2025 Outlook

11 juil. 2025, 15:41 UTC

Market Talk

Oil, Gas Prices Not Seen Supporting Drilling Boom -- Market Talk

Comparaison

Variation de prix

Integra LifeSciences Holdings Corp prévision

Objectif de Prix

By TipRanks

11.39% hausse

Prévisions sur 12 Mois

Moyen 14.67 USD  11.39%

Haut 25 USD

Bas 10 USD

Basé sur 8 analystes de Wall Street proposant des objectifs de prix à 12 mois pour Microsoft Corp. au cours des 3 derniers mois.

Note du Consensus

By TipRanks

Neutre

8 ratings

1

Achat

4

Maintien

3

Vente

Score Technique

By Trading Central

12.75 / 16.41Support & Résistance

Court Terme

Strong Bearish Evidence

Moyen Terme

Strong Bearish Evidence

Long Terme

Weak Bearish Evidence

Sentiment

By Acuity

174 / 376Classement par Soins de santé

Sentiment de l'Actualité

Neutral

Volatilité

Inférieur à la moyenne

Changement du Volume d'Actualités (RCV)

Moyen

Éléments financiers

Frais Généraux et Administratifs

Dépenses d'exploitation

Résultat avant impôt

Ventes

Coût des ventes

Marge brute des ventes

Charges d'intérêt sur la dette

EBITDA

Bénéfice d'exploitation

$

À Propos Integra LifeSciences Holdings Corp

Integra LifeSciences Holdings Corporation manufactures and sells surgical instruments, neurosurgical products, and wound care products for use in neurosurgery, neurocritical care, and otolaryngology. It operates in two segments, Codman Specialty Surgical and Tissue Technologies. The company offers neurosurgery and neuro critical care products, including tissue ablation equipment, dural repair products, cerebral spinal fluid management devices, intracranial monitoring equipment, and cranial stabilization equipment; and surgical headlamps and instrumentation, as well as after-market services. It also sells instrument patterns, and surgical and lighting products to hospitals and surgery centers, as well as dental, podiatry, and veterinary offices. In addition, the company provides regenerative technology products for the treatment of acute wounds; and surgical tissue repair products for hernia, tendon, peripheral nerve repair and protection. Further, it offers skin and wound repair, plastics and surgical reconstruction products, bone grafts, and nerve and tendon repair products. The company offers its products directly through various sales forces and other distribution channels to the hospitals, integrated health networks, group purchasing organizations, clinicians, surgery centers, and health care providers in the United States, Europe, Asia Pacific, and internationally. Integra LifeSciences Holdings Corporation was incorporated in 1989 and is headquartered in Princeton, New Jersey.